Read the Medication Guide provided by your pharmacist before you start using leuprolide and each time you get a refill. If you have any questions, ask your doctor or pharmacist. This medication is ...

ABBOTT PARK, Ill., June 20, 2011 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved a new 45 mg for six-month administration formulation of Lupron ...

Cipla is introducing leuprolide acetate injection depot, 22.5 mg, which is the generic of AbbVie’s Lupron Depot. It is indicated for palliative treatment of advanced prostate cancer. Leuprolide ...

Leuprolide acetate 45mg; depot susp for IM inj; preservative-free. Store between 20° to 25°C (68° to 77°F); excursions permitted to 15°C to 30°C (59°F to86°F). Give as single IM inj into gluteal area, ...

Combined mTOR and AKT inhibition in renal cell carcinoma (RCC). Background: Leuprolide acetate is a synthetic analog of gonadotropin hormone-releasing hormone (GnRH-a) that reduces serum testosterone ...

Leuprolide acetate for injection is used to treat the symptoms associated with advanced prostate cancer by way of palliative treatment of advanced prostatic cancer. Aurobindo’s subsidiary, Eugia ...

Cipla Limited and its wholly owned subsidiary Cipla USA Inc. , today announced the launch of Leuprolide Acetate Injection Depot 22.5mg. The product was approved by the United States Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . A subcutaneous injection of leuprolide acetate every 6 months was effective and well tolerated in treating ...

Dec. 29, 2004 -- The U.S. Food and Drug Administration (FDA) approved in October revisions to safety labeling to advise healthcare professionals of the following changes: leuprolide acetate is ...

Leuprolide acetate 1mg/0.2mL; soln for SC inj; contains benzyl alcohol. Leuprolide acetate, a gonadotropin releasing hormone (GnRH) agonist, acts as a potent inhibitor of gonadotropin secretion when ...